Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBSX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBoston Scientific Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 19, 1992
āļāļĩāļāļĩāđāļMahoney (Michael F)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ53000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 19
āļāļĩāđāļāļĒāļđāđ300 Boston Scientific Way
āđāļĄāļ·āļāļMARLBOROUGH
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ01752-1234
āđāļāļĢāļĻāļąāļāļāđ15086834000
āđāļ§āđāļāđāļāļāđhttps://www.bostonscientific.com/en-US/Home.html
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBSX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 19, 1992
āļāļĩāļāļĩāđāļMahoney (Michael F)
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. John E. Sununu
Independent Director
Mr. Vance R. Brown
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Ms. Ellen M. Zane
Independent Director
Mr. David C. Habiger
Independent Director
Mr. Yoshiaki Fujimori
Independent Director
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiovascular
Executive Vice President, Group President - Cardiovascular
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
Mr. John E. Sununu
Independent Director
Mr. Vance R. Brown
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
Ms. Ellen M. Zane
Independent Director
Mr. David C. Habiger
Independent Director